openPR Logo
Press release

Antivirals Global Market Report 2024 - By Size, Trends, Growth, Demand And Analysis, Forecast To 2033

12-26-2023 08:21 AM CET | Health & Medicine

Press release from: The Business research company

Antivirals Global Market Report 2024 - By Size, Trends, Growth,

The Business Research Company's global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company's Antivirals Global Market Report 2023 identifies public-private funding for life science research globally as the major driver for the Antivirals market's growth in the forecast periodCurrently, there are no drugs or vaccines approved for the treatment of COVID-19 disease, however, there are several vaccines and drugs in the pipeline, that are yet to be approved or launched. Governments around the world announced new grant funds for researchers in vaccines, treatment, and diagnostics.

The antivirals market size has grown strongly in recent years. It will grow from $97.72 billion in 2023 to $105.73 billion in 2024 at a compound annual growth rate (CAGR) of 8.2%. The growth in the historic period can be attributed to viral disease prevalence, public health concerns, patent expirations, government initiatives. The antivirals market size is expected to see strong growth in the next few years. It will grow to $143.83 billion in 2028 at a compound annual growth rate (CAGR) of 8.0%.

Download Free Sample Of Antivirals Market Report - https://www.thebusinessresearchcompany.com/sample_request?id=2437&type=smp

Major competitors in the Antivirals market are AbbVie Inc., Bristol-Myers-Squibb Co., Chemical Industrial & Pharmaceutical Laboratories Ltd., F. Hoffmann-La Roche Ltd., Gilead Sciences Inc.

A key trend in the Antivirals market includes develop drugs to treat different viral infections. Biopharmaceutical companies are developing vaccines for the treatment of novel COVID-19. Technological advances in the pharmaceutical sector include the development of nucleic acid vaccines that are DNA- and RNA-based, and which enable the human body to produce vaccine antigens. For instance, in October 2021, Merck & Co. Inc., a US-based pharmaceutical company and Ridgeback Biotherapeutics a US-based biotechnology company launched Oral Antiviral Molnupiravir. Oral Antiviral Molnupiravir is an antiviral medication for COVID-19. This was approved by the US Food and Drug Administration (FDA), a US-based federal agency for the treatment of mild-to-moderate COVID-19 for emergency use. This is an orally administered nucleoside analog that inhibits the replication of SARS-CoV-2, the causative agent of COVID-19.

Read More On The Global Antivirals Market Report Here: https://www.thebusinessresearchcompany.com/report/antivirals-global-market-report

The Antivirals market is segmented -
• By Type: Branded, Generic
• By Drug Class: DNA Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease Inhibitors, Neuraminidase Inhibitors, Other Drug classes
• By Application: HIV, Hepatitis, Herpes, Influenza, Other Applications
• By Geography: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. North America was the largest region in the Antivirals market.

The Business Research Company's "Global Antivirals Market Report 2023" provides a thorough understanding of the market across 60 geographies. The report covers market size, growth rate, segments, drivers and trends in every region and country. In addition, the report offers insights on historical and forecast growth, helping players analyze and strategize better.

Explore Buying Options For The Antivirals Market Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2437

The Table Of Content For The Antivirals Market Include:
1. Executive Summary
2. Antivirals Market Characteristics
3. Antivirals Market Trends And Strategies
4. Antivirals Market - Macro Economic Scenario
5. Global Antivirals Market Size and Growth
..................
31. Global Antivirals Market Competitive Benchmarking
32. Global Antivirals Market Competitive Dashboard
33. Key Mergers And Acquisitions In The Antivirals Market
34. Antivirals Market Future Outlook and Potential Analysis
35. Appendix.

Contact us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Latest Trending Press Releases: https://www.thebusinessresearchcompany.com/press-release.aspx

Want To Know More About The Business Research Company?
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model - World's Most Comprehensive Database
The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Antivirals Global Market Report 2024 - By Size, Trends, Growth, Demand And Analysis, Forecast To 2033 here

News-ID: 3337509 • Views:

More Releases from The Business research company

Laparoscopy Devices Market to Grow to $17.13 Billion by 2028, Fueled by Minimally Invasive Surgery
Laparoscopy Devices Market to Grow to $17.13 Billion by 2028, Fueled by Minimall …
The laparoscopy devices market size has grown strongly in recent years. It will grow from $12.17 billion in 2023 to $13.1 billion in 2024 at a compound annual growth rate (CAGR) of 7.6%. The growth in the historic period can be attributed to improved surgeon training programs, enhanced safety and efficacy, shift towards minimally invasive surgery, evolution in energy-based devices, early adoption challenges. The laparoscopy devices market size is expected to
Inventory Tags Market to Grow to $7.04 Billion by 2028, Fueled by Barcode Technology
Inventory Tags Market to Grow to $7.04 Billion by 2028, Fueled by Barcode Techno …
The inventory tags market size has grown steadily in recent years. It will grow from $5.55 billion in 2023 to $5.8 billion in 2024 at a compound annual growth rate (CAGR) of 4.5%. The growth in the historic period can be attributed to barcode technology adoption, development of rfid tags, manual inventory management systems, standardization of tagging systems, introduction of qr codes. The inventory tags market size is expected to see
Infection Control Market to Grow to $164.6 Billion by 2028: Major Trends, Technological Advancements, Growth Drivers And Forecast 2024-2033
Infection Control Market to Grow to $164.6 Billion by 2028: Major Trends, Techno …
The infection control market size has grown strongly in recent years. It will grow from $119.1 billion in 2023 to $126.25 billion in 2024 at a compound annual growth rate (CAGR) of 6.0%. The growth in the historic period can be attributed to healthcare-associated infections (hais), stringent regulatory standards, rising awareness of infectious diseases, globalization and travel, increased healthcare expenditure. The infection control market size is expected to see strong growth
Hyperpigmentation Disorder Market to Reach $7.73B by 2028 within Forecast Period 2024-2033 Driven by Surge in Pigmentation Disorders
Hyperpigmentation Disorder Market to Reach $7.73B by 2028 within Forecast Period …
The hyperpigmentation disorder treatment market size has grown strongly in recent years. It will grow from $5.3 billion in 2023 to $5.69 billion in 2024 at a compound annual growth rate (CAGR) of 7.5%. The growth in the historic period can be attributed to clinical trials and research, advances in chemical peels, cultural shift towards skincare, emphasis on non-invasive options, demand for natural products. The hyperpigmentation disorder treatment market size is

All 5 Releases


More Releases for Antiviral

Antiviral Drugs Market Size, Report 2022-2030
Acumen Research and Consulting has announced the addition of the "Antiviral Drugs Market" report to their offering. The Antiviral Drugs Market Report 2030 is an in depth study analyzing the current state of the Antiviral Drugs Market. It provides brief overview of the market focusing on definitions, market segmentation, end-use applications and industry chain analysis. The study on Antiviral Drugs Market provides analysis of global market covering the industry trends, recent
Antiviral Drugs Market
“Antiviral Drugs Market” study by “The Insight Partners” provides details about the market dynamics affecting the market, Market scope, Market segmentation and overlays shadow upon the leading market players highlighting the favorable competitive landscape and trends prevailing over the years. This Report encloses comprehensive analysis on the market and are assessed through volume and value data validated on three approaches including top companies revenues. It concludes with precise and authentic market
Antiviral therapies Market: High Cost of Antiviral therapies Is a Major Restrain …
Post COVID-19 Impact on Antiviral Therapies Market –With the emergence of the COVID-19 crisis, the world is fighting a health pandemic as well as an economic emergency, almost impacting trillions of dollars of revenues. Research Dive’ group of skilled analysts provide a solution to help the companies to survive and sustain in this economic crisis. We support companies to make informed decisions based on our findings resulting from the comprehensive
Increasing Utilization of Antiviral Drugs, During the COVID-19 Outbreak, to Prom …
According to antiviral therapies market analysis by Research Dive, the global market forecast will surpass $66,016.5 million in 2027, growing at a 3.1% CAGR from $51,913.1 million in the year2019. Antiviral Therapies Market, COVID-19 Impact: The global antiviral therapies market has responded positively to the pandemic owing to rise in the utilization of antiviral drugs in the development of effective medicines for the COVID-19 treatment. In addition, leading players in the global
Coronavirus's Impact On Antiviral Packaging Market
Antiviral Packaging Market – An Overview The coronavirus pandemic keeps on revamping the idea of worldwide society in 2020, and with it changes the perspectives and practices of buyers now and for a long time to come. In any case, the prompt effect on buyers’ interests about viral introduction and questions hanging about the infection’s capacity to make due on surfaces, may fuel an any longer enduring interest for new bundling
Magniflex Introduces Antiviral and Antibacterial Collection
Magniflex, the renowned mattress manufacturer from Italy, has always had innovation in its DNA, as the success, accolades, and certifications obtained over the years prove, and the goal has always been to introduce innovative solutions to common issues that affect the quality of our sleep. As a response to the COVID-19 global pandemic, Magniflex conducted scientific and technological research in collaboration with prominent experts in order to produce MagniProtect: an